Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

RUSSE / Russian Spiriva® Safety & Efficacy Study

Trial Profile

RUSSE / Russian Spiriva® Safety & Efficacy Study

Phase of Trial: Phase IV

Latest Information Update: 11 Jun 2014

At a glance

  • Drugs Tiotropium bromide (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Acronyms RUSSE
  • Sponsors Boehringer Ingelheim
  • Most Recent Events

    • 20 Jan 2010 Actual number of patients (407) added as reported by ClinicalTrials.gov record.
    • 29 Feb 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top